Take Solutions Intrinsic Value

TAKE • Healthcare
Current Stock Price
₹12.66
Primary Intrinsic Value
₹37.84
Market Cap
₹19.0 Cr
+100.0% Upside
Median Value
₹25.32
Value Range
₹11 - ₹38
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

TAKE Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹37.84 ₹30.27 - ₹45.41 +198.9% EPS: ₹1.72, Sector P/E: 22x
Book Value Method asset ₹28.00 ₹25.20 - ₹30.80 +121.2% Book Value/Share: ₹14.00, P/B: 2.0x
Revenue Multiple Method revenue ₹25.32 ₹22.79 - ₹27.85 +100.0% Revenue/Share: ₹18.67, P/S: 2.0x
EBITDA Multiple Method earnings ₹25.32 ₹22.79 - ₹27.85 +100.0% EBITDA: ₹28.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹31.65 ₹25.32 - ₹37.98 +150.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹11.01 ₹9.91 - ₹12.11 -13.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹26.57 ₹23.91 - ₹29.23 +109.9% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹25.32 ₹22.79 - ₹27.85 +100.0% ROE: 114.3%, P/E Multiple: 16x
Graham Defensive Method conservative ₹23.28 ₹20.95 - ₹25.61 +83.9% EPS: ₹1.72, BVPS: ₹14.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check TAKE share price latest .

Valuation Comparison Chart

TAKE Intrinsic Value Analysis

What is the intrinsic value of TAKE?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Take Solutions (TAKE) is ₹25.32 (median value). With the current market price of ₹12.66, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹11.01 to ₹37.84, indicating ₹11.01 - ₹37.84.

Is TAKE undervalued or overvalued?

Based on our multi-method analysis, Take Solutions (TAKE) appears to be trading below calculated value by approximately 100.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Debt to Equity Ratio 1.76 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 114.3% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Asset Turnover Ratio 0.76x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-16 Cr ₹-16 Cr Negative Cash Flow 3/10
March 2024 ₹9 Cr ₹5 Cr Positive Free Cash Flow 8/10
March 2023 ₹20 Cr ₹19 Cr Positive Free Cash Flow 8/10
March 2022 ₹30 Cr ₹30 Cr Positive Free Cash Flow 8/10
March 2021 ₹135 Cr ₹106 Cr Positive Free Cash Flow 8/10